Last checked at 
(Alliance News) - Fusion Antibodies PLC said Wednesday that its Chief Executive Officer and two Non-Executive Directors have bought around GBP31,794 in shares in the company in deals on Tuesday.
Chief Executive Officer Paul Kerr purchased 6,920 shares at a price of 72.896 pence per share, for a total of GBP5,044. He now holds 540,710 shares in total, representing a 2.5% stake in the company.
Non-Executive Director Alan Mawson acquired 10,000 shares for 59 pence each, at GBP5,900 in total. He now holds 53,988 shares overall.
Finally, Non-Executive Director Sonya Ferguson bought 30,000 shares for 69.5 pence per share, at a total of GBP20,850. She now holds 60,900 shares in total, reflecting a 0.3% interest in the company.
Shares in the antibody engineering services firm closed 3.1% higher at 67.50 pence in London on Wednesday.
